If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Board Changes

Today 07:00

RNS Number : 2289L
Transense Technologies PLC
07 July 2026
 

7 July 2026

Transense Technologies plc

("Transense" or the "Company")

Board Changes

Retirement of Chief Financial Officer and Appointment of Finance Director (designate)

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement solutions, announces that Melvyn Segal has informed the Board of his intention to retire from the role of Chief Financial Officer ("CFO") and Company Secretary with effect from the Company's Annual General Meeting (AGM) in November 2026. The Board also announces the appointment of Richard Michael Pearce ACA as Finance Director with effect from 1 September 2026.

Melvyn will remain with the Company in an executive capacity for a handover period until the AGM, and will subsequently remain on the Board as a non-executive director for a further year. The Board would like to thank Melvyn for his significant contribution to Transense over many years, during which the Company and its prospects have been transformed.

Richard brings over twenty years of financial, commercial and listed company experience to Transense. Since qualifying as a Chartered Accountant with Ernst & Young in 1999, he has held senior finance roles at GE Healthcare and TD Williamson, and most recently as Finance Director at Lombard Medical where he oversaw a scale-up in revenues from £6m to £25m per annum since 2018. He will initially work alongside Melvyn in a non-board role as Finance Director, with progression to the Board leading the Group's finance function when Melvyn's steps down as CFO in November 2026.

The Board welcomes Richard to his new role and we look forward to his contribution to delivery of the future growth strategy.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKABQCBKDDOK
Date   Source Headline
11th Mar 20085:43 pmRNSDirector Details
25th Feb 20082:41 pmRNSHolding(s) in Company
8th Feb 20087:30 amRNSDirector Declaration
8th Feb 20087:00 amRNSBoard and Adviser Change
16th Jan 20082:47 pmRNSHolding(s) in Company
4th Jan 200812:08 pmRNSResult of General Meeting
13th Dec 200710:08 amRNSGrant of Options
10th Dec 200712:56 pmRNSFurther update
7th Dec 20078:00 amRNSAdditional Listing
3rd Dec 200712:18 pmRNSProposed Directorate Changes
21st Nov 20077:30 amRNSRestoration - Transense Techn
21st Nov 20077:30 amRNSFurther Update
20th Nov 200712:14 pmRNSHolding(s) in Company
16th Nov 20073:51 pmRNSResult of EGM
16th Nov 20073:51 pmRNSSuspension - Transense Tech
16th Nov 200710:47 amRNSHolding(s) in Company
15th Nov 20077:03 amRNSGeneral Meeting update
13th Nov 20073:58 pmRNSSchedule 1 - Transense Techno
13th Nov 20077:00 amRNSGeneral Meeting update
2nd Nov 20075:51 pmRNSSchedule 1 - Transense Techno
2nd Nov 200712:53 pmRNSConference Call
26th Oct 20077:30 amRNSConference call
24th Oct 200711:02 amRNSHolding(s) in Company
22nd Oct 20071:30 pmRNSRestoration - Transense Techn
22nd Oct 20071:30 pmRNSAcquisition
17th Oct 20077:00 amRNSHolding(s) in Company
11th Oct 200710:34 amRNSStatement re. Suspension
11th Oct 200710:30 amRNSSuspension - Transense Tech.
28th Sep 20077:03 amRNSInterim Results
25th Sep 20074:25 pmRNSHolding(s) in Company
9th Aug 200711:44 amRNSAIM Rule 26 Compliance
8th Aug 200712:11 pmRNSPatent Agreement
20th Jun 20073:45 pmRNSDirector/PDMR Shareholding
12th Jun 20073:39 pmRNSTotal Voting Rights
25th May 20073:10 pmRNSAGM Statement
24th May 200711:30 amRNSAGM Statement
10th May 20076:04 pmRNSDirector/PDMR Shareholding
19th Apr 20078:00 amRNSDirector/PDMR Shareholding
17th Apr 200710:29 amRNSDirector Resignation
11th Apr 200712:17 pmRNSDirector/PDMR Shareholding
10th Apr 20074:16 pmRNSHolding(s) in Company
30th Mar 20077:03 amRNSFinal Results
14th Mar 20073:49 pmRNSHolding(s) in Company
8th Mar 20072:59 pmRNSHolding(s) in Company
1st Mar 20075:32 pmRNSHolding(s) in Company
26th Feb 20074:14 pmRNSHolding(s) in Company
22nd Feb 20072:20 pmRNSHolding(s) in Company
22nd Feb 20072:15 pmRNSHolding(s) in Company
14th Feb 20074:05 pmRNSHolding(s) in Company
15th Jan 20075:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.